Ursodiol



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 26.7%
Foetal Exposure During Pregnancy 9.0%
Liver Disorder 8.6%
Biliary Cirrhosis Primary 7.8%
Hepatitis C 7.1%
Cholangitis Sclerosing 5.5%
Cholelithiasis 5.1%
Cholestasis 4.3%
Bile Duct Stone 3.1%
Crohn's Disease 2.7%
Asthma 2.4%
Cerebral Infarction 2.4%
Hepatic Function Abnormal 2.4%
Hyperthyroidism 2.4%
Transplant 2.4%
Hypertension 2.0%
Ascites 1.6%
Autoimmune Hepatitis 1.6%
Chronic Hepatitis 1.6%
Drug Use For Unknown Indication 1.6%
Interstitial Lung Disease 16.4%
Liver Transplant 9.8%
Jaundice 6.6%
Bile Duct Stone 4.9%
Disease Progression 4.9%
Lymphocyte Stimulation Test Positive 4.9%
Maternal Drugs Affecting Foetus 4.9%
Pruritus 4.9%
Renal Disorder 4.9%
Urticaria 4.9%
Anaemia 3.3%
Biliary Tract Infection 3.3%
Dyspnoea 3.3%
Hepatic Function Abnormal 3.3%
Hepatic Neoplasm Malignant 3.3%
Liver Disorder 3.3%
Liver Function Test Abnormal 3.3%
Malignant Neoplasm Progression 3.3%
Musculoskeletal Disorder 3.3%
Pruritus Generalised 3.3%
Secondary
Drug Use For Unknown Indication 40.4%
Product Used For Unknown Indication 10.5%
Prophylaxis 8.4%
Hepatitis C 6.0%
Foetal Exposure During Pregnancy 3.3%
Insomnia 3.3%
Hypertension 3.0%
Ill-defined Disorder 3.0%
Autoimmune Hepatitis 2.7%
Drug Exposure During Pregnancy 2.4%
Hepato-lenticular Degeneration 2.4%
Pruritus 2.1%
Asthma 1.8%
Cholestasis Of Pregnancy 1.8%
Renal Transplant 1.8%
Biliary Cirrhosis Primary 1.5%
Crohn's Disease 1.5%
Liver Transplant 1.5%
Cholangitis Sclerosing 1.2%
Cholelithiasis 1.2%
Jaundice 41.3%
Premature Baby 12.7%
Aplastic Anaemia 3.2%
Drug Exposure During Pregnancy 3.2%
Dysmorphism 3.2%
Liver Function Test Abnormal 3.2%
Maternal Exposure During Pregnancy 3.2%
Rash 3.2%
Retinal Haemorrhage 3.2%
Schizophrenia 3.2%
Toxic Epidermal Necrolysis 3.2%
Tubulointerstitial Nephritis 3.2%
Withdrawal Syndrome 3.2%
Abdominal Pain 1.6%
Autoimmune Hepatitis 1.6%
Bile Duct Stone 1.6%
Blood Bilirubin Increased 1.6%
Brain Malformation 1.6%
Colonic Haematoma 1.6%
Complications Of Transplanted Kidney 1.6%
Concomitant
Product Used For Unknown Indication 39.5%
Prophylaxis 10.6%
Drug Use For Unknown Indication 9.8%
Infection Prophylaxis 5.0%
Prophylaxis Against Graft Versus Host Disease 4.0%
Bone Marrow Conditioning Regimen 3.6%
Hypertension 3.1%
Premedication 2.9%
Crohn's Disease 2.7%
Antifungal Prophylaxis 2.4%
Acute Myeloid Leukaemia 2.1%
Rheumatoid Arthritis 2.1%
Hepatitis C 2.0%
Pain 1.8%
Insomnia 1.7%
Constipation 1.5%
Antiviral Prophylaxis 1.4%
Diabetes Mellitus 1.3%
Prophylaxis Against Gastrointestinal Ulcer 1.3%
Hepatic Neoplasm Malignant 1.2%
Vomiting 16.1%
White Blood Cell Count Decreased 9.4%
Pyrexia 6.5%
Sepsis 5.4%
Thrombocytopenia 5.4%
Weight Increased 5.4%
Weight Decreased 5.2%
Death 4.9%
Pneumonia 4.5%
Venoocclusive Liver Disease 4.3%
Diarrhoea 3.8%
Venoocclusive Disease 3.8%
Tremor 3.4%
Hepatic Failure 3.3%
Platelet Count Decreased 3.3%
Renal Failure Acute 3.3%
Septic Shock 3.3%
Jaundice 2.9%
Nausea 2.9%
Rash 2.9%
Interacting
Drug Use For Unknown Indication 26.7%
Anxiety 13.3%
Bipolar I Disorder 13.3%
Depression 13.3%
Liver Disorder 13.3%
Smoking Cessation Therapy 13.3%
Rheumatoid Arthritis 6.7%
Depression 33.3%
Drug Interaction 33.3%
Transaminases Increased 33.3%